Suppr超能文献

动物健康领域中的氟喹诺酮类药物。

Fluoroquinolones in animal health.

作者信息

Brown S A

机构信息

Animal Health Drug Metabolism, Pharmacia & Upjohn, Inc., Kalamazoo, MI 49001, USA.

出版信息

J Vet Pharmacol Ther. 1996 Feb;19(1):1-14. doi: 10.1111/j.1365-2885.1996.tb00001.x.

Abstract

The fluoroquinolones are a series of synthetic antibacterial agents that are undergoing extensive investigation for both human and veterinary use in the treatment of a variety of bacterial infections. These agents work through the inhibition of DNA gyrase, interfering with the supercoiling of bacterial chromosomal material. As a result, these agents are rapidly bactericidal primarily against gram-negative bacteria, mycoplasma, and some gram-positive bacteria, with most having little to no activity against group D streptococci and obligate anaerobic bacteria. Resistance develops slowly and is almost always chromosomal and not plasmid-mediated. However, development of resistance to the fluoroquinolones and transfer of that resistance among animal and human pathogens have become a hotly debated issue among microbiologists. The fluoroquinolones are a current antimicrobial class whose use in veterinary medicine is being scrutinized. From a pharmacokinetic perspective, these agents are variably but well absorbed from the gastrointestinal tract and almost completely absorbed from parenteral injection sites, and they are well distributed to various tissues in the body. The fluoroquinolones are metabolized and renally excreted, with many of them having approximately equal excretion by the hepatic and the renal excretory systems. The primary toxicity observed at therapeutic doses involves the gastrointestinal system and phototoxicity, although at higher doses central nervous system toxicity and ocular cataracts are observed. Administration to immature animals may result in erosive arthropathies at weight-bearing joints, and administration of high doses to pregnant animals results in maternotoxicity and occasionally embryonic death. The fluoroquinolones are approved for indications such as urinary tract infections and soft tissue infections in dogs and cats and colibacillosis in poultry. Approval for bovine respiratory disease in the United States is being sought. Other indications for which the fluoroquinolones have been used in animal health include deep-seated infections, prostatitis, and other bacterial infections resistant to standard antimicrobial therapy.

摘要

氟喹诺酮类是一系列合成抗菌剂,正在接受广泛研究,用于人和兽医治疗各种细菌感染。这些药物通过抑制DNA回旋酶起作用,干扰细菌染色体物质的超螺旋。因此,这些药物主要对革兰氏阴性菌、支原体和一些革兰氏阳性菌具有快速杀菌作用,大多数对D组链球菌和专性厌氧菌几乎没有活性。耐药性发展缓慢,几乎总是染色体介导的,而非质粒介导。然而,氟喹诺酮类耐药性的产生以及这种耐药性在动物和人类病原体之间的转移,已成为微生物学家激烈争论的问题。氟喹诺酮类是目前正在接受兽医医学使用审查的一类抗菌药物。从药代动力学角度来看,这些药物从胃肠道的吸收程度各不相同但良好,从非肠道注射部位几乎完全吸收,并且它们在体内能很好地分布到各种组织。氟喹诺酮类经代谢后经肾脏排泄,其中许多药物通过肝脏和肾脏排泄系统的排泄量大致相等。治疗剂量下观察到的主要毒性涉及胃肠道系统和光毒性,尽管在更高剂量下会观察到中枢神经系统毒性和眼部白内障。给未成熟动物用药可能导致负重关节出现侵蚀性关节病,给怀孕动物高剂量用药会导致母体毒性,偶尔还会导致胚胎死亡。氟喹诺酮类已被批准用于犬猫尿路感染、软组织感染以及家禽大肠杆菌病等适应症。美国正在寻求批准用于牛呼吸道疾病。氟喹诺酮类在动物健康领域使用的其他适应症包括深部感染、前列腺炎以及对标准抗菌治疗耐药的其他细菌感染。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验